Statins in Alcoholic and Non-Alcoholic Fatty Liver Disease and Chronically Elevated Liver Enzymes

The prevalence of alcoholic liver disease and non-alcoholic patients has nearly doubled over the past decades worldwide. Alcoholic among with chronic increased arisen due to alcohol consumption obesity. diagnosis plays a crucial role in treating such conditions based on stages functioning. elevated enzymes are key characterizing identifying (ALD) NAFLD. Later on, there is progression by developing fibrosis cirrhosis, leading carcinoma. other state, steatohepatitis, associated an increase liver-related can lead mortality. Risk factors for both diseases growing, various complications health. There no specific treatment up date these conditions, but statins play managing several conditions. commonly used drug hydroxymethylglutaryl coenzyme A (HMG Co-A) reductase inhibitors. It also known as statins, which help normalize plasma aminotransferases. As result, external damage considered safe Statin medication at low moderate dose usage. OBJECTIVES: main scope this review study like pharmacological actions, adverse events, biochemical cell imaging results ALD different types patients’ clinical data safety statin therapy were concluded review. Fatty changes studied using drugs. Alanine transaminase (ALT), Aspartate (AST), Gamma-glutamyl Transferase (GGT), effectiveness vital concepts